Improving Community Clinical Trial Participation

Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement. Guest: Alex Spira, MD, PhD, FACP, Medical Oncologist; Director, VCS Research Institute & Phase I Trial Program, Virginia Cancer Specialists Related Content: A Focus on Targeting KRAS G12C in NSCLC KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors, New England Journal of Medicine Featured Clinical Research: Barriers to Clinical Trials Participation Cancer Center Brings Clinical Trials to Diverse Population Episode 16: IO Clinical Trials During COVID-19 The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.